Stock Market News4 weeks Biotech ETF (XBI) ended a diagonal – Looking for buying dips FXStreet
X4 weeks Corcept Therapeutics: A Most Promising And Compelling Biotech Seeking Alpha
X4 weeks A Post-Mortem on Cassava Sciences Zacks
X4 weeks Mizuho’s Jared Holz on what Trump’s FDA pick means for biotech innovation YouTube
X4 weeks Finding Winners In Biotech, Probably The Riskiest Sector Seeking Alpha
X4 weeks Cassava Sciences’ stock craters after Alzheimer’s disease trial fails to meet its goals MarketWatch
X1 month OK, Here is the main reason that why Biotech companies don’t make money in China Reddit
X1 month Why is NVO willing to sell drugs at such low price in China? Reddit
X1 month Why is NVO willing to sell drugs at such low price in China? Reddit
X1 month Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & More Zacks
X1 month China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug Investing.com
X1 month Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? Zacks
X1 month Regeneron: The Biotech Stock To Buy Now Seeking Alpha
X1 month Biotech: 3 Reasons The Recent Selloff Is A Buying Opportunity For XBI (Upgrade) Seeking Alpha
X1 month Best Biotech Stocks Right Now Benzinga
X1 month The Zacks Analyst Blog Highlights SPDR S&P Biotech ETF, SPDR S&P Semiconductor ETF, First Trust Indxx Aerospace & Defense ETF, First Trust NASDAQ-100-Technology Sector Index Fund and iShares U.S. Digital Infrastructure and Real Estate ETF Zacks
X1 month Here are 4 biotech stocks that could get a boost from Trump’s new regulatory climate MarketWatch
X1 month Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It Zacks
X1 month Biotech Stocks To Watch And Pharma Industry News Investor's Business Daily
X1 month RBC’s top 10 questions and answers on biotech stocks Investing.com
X1 month Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer Therapy Zacks
X1 month The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks Investor's Business Daily
X1 month Trump Taps RFK for HHS: Time to Avoid Biotech? Zacks
X1 month The Stocks Our Experts Are Trading Now InvestorPlace
X1 month Ocugen (OCGN) Reports Q3 Loss, Misses Revenue Estimates Zacks
X1 month Sagimet: More Than Just A MASH Drug Development Biotech Seeking Alpha
X1 month Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data Zacks
X1 month BNTX to Boost Oncology Pipeline With Biotheus Acquisition, Stock Up Zacks
X1 month Citi initiates coverage on 5 new biotech stocks Investing.com
X1 month Oncolytics Biotech Inc. (ONCY) Q3 2024 Earnings Call Transcript Seeking Alpha
X1 month This biotech’s stock could double if its treatment for major depressive disorder succeeds, says Mizuho MarketWatch
X1 month FibroGen (FGEN) Reports Q3 Loss, Tops Revenue Estimates Zacks
X1 month Legend Biotech Corporation (LEGN) Q3 2024 Earnings Call Transcript Seeking Alpha
X1 month Top Biotech Neurogene Crashes 44%, Wiping Out Its Sprint On A $200 Million Deal Investor's Business Daily
X1 month Bristol Myers Stock Trading Near 52-Week High: Time to Buy or Sell? Zacks
X2 months 5 Small Drug Stocks to Buy as Trump Gets Re-Elected Zacks
X2 months Biotech startup works on new regenerative drugs YouTube
X2 months Moderna’s stock pops after biotech ekes out a surprise profit, and revenue beats by a wide margin MarketWatch
X2 months Gilead’s third-quarter earnings beat by a wide margin, and biotech raises guidance MarketWatch
X2 months Biotech Stocks Edge Higher. Could Trump 2.0 Mean More Innovation, Dealmaking? Investor's Business Daily
X2 months What’s in Store for These 5 Drug & Biotech Stocks in Q3 Earnings? Zacks
X2 months Krystal Q3 Earnings and Sales Top Estimates, Vyjuvek Gains Traction Zacks
X2 months Krystal Biotech, Inc. (KRYS) Q3 2024 Earnings Call Transcript Seeking Alpha
X2 months Gilead Science to Report Q3 Earnings: What’s in the Cards? Zacks
X2 months Amgen: A Biotech Giant Offering Value And Growth In A Frothy Market Seeking Alpha
X2 months Buffett Still Building This Stake, Plus Huge Insider Buy in Biotech IPO 24/7 Wall St.
X2 months ADMA Biologics, A Top 1% Stock, Skyrockets After Settling Its Accounting Debacle Investor's Business Daily
X2 months Regeneron Takes A Ghastly Turn As High-Dose Eylea Lags And Biosimilars Loom Investor's Business Daily
X2 months Short Interest in IO Biotech, Inc. (NASDAQ:IOBT) Declines By 12.7% MarketBeat
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.